PPIDT00068
Drug Information
| Name | Tositumomab |
|---|---|
| Sequence | QAYLQQSGAELVRPGASVKMSCKASGYTFTSYNMHWVKQTPRQGLEWIGAIYPGNGDTSYNQKFKGKATLTVDKSSSTAYMQLSSLTSEDSAVYFCARVVYYSNSYWYFDVWGTGTTVTVSGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKAEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK |
| DrugBank_ID | DB00081 |
| Type | biotech |
| Indication | For treatment of non-Hodgkin's lymphoma (CD20 positive, follicular) |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Kit | Intravenous |
|
| Injection | Intravenous |
0.61 mCi/1mL
|
| Injection | Intravenous |
5.6 mCi/1mL
|
| Kit; solution | Intravenous |
14 mg / mL
|